Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting

Adriana M. JosephThe Nathan Kline Institute, Research Foundation for Mental Hygiene, Orangeburg, NY, USACorrespondence[email protected]

, MPH,

Marc W. ManseauNew York University School of Medicine, Department of Psychiatry, One Park Avenue, New York, NY, USA;Bellevue Hospital Center, Department of Psychiatry, New York, NY, USA

, MD, MPH,

Monique LalaneNew York University School of Medicine, Department of Psychiatry, One Park Avenue, New York, NY, USA;Bellevue Hospital Center, Department of Psychiatry, New York, NY, USA

, LCSW,

Amit RajpariaNew York University School of Medicine, Department of Psychiatry, One Park Avenue, New York, NY, USA;Bellevue Hospital Center, Department of Psychiatry, New York, NY, USA

, MD &

Crystal Fuller LewisNew York University School of Medicine, Department of Psychiatry, One Park Avenue, New York, NY, USA;Bellevue Hospital Center, Department of Psychiatry, New York, NY, USA

, PhD

Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date